Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Suyu Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0126-2646; OpenAlex author ID A5035273559; NIH RePORTER profile ID 12548494. Sources: OpenAlex.

Their work

Papers
9 (first author 3, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
62
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers · 2025: none · 2026: 1 paper, 1 grant

Papers 9

  1. Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study. Co-author DOI 10.1158/1078-0432.ccr-25-4061↗
  2. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Co-author DOI 10.1002/cam4.7434↗
  3. Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. Co-author DOI 10.1016/j.gastha.2024.08.002↗
  4. Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies. Co-author DOI 10.1016/j.pan.2024.10.012↗
  5. Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II T… Co-author DOI 10.1200/jco.24.00081↗
  6. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. First author DOI 10.1016/j.cca.2023.117567↗
  7. PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer. First author DOI 10.1186/s12885-021-09095-7↗
  8. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. First author DOI 10.1158/1940-6207.capr-20-0303↗
  9. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djw341↗

Grants 1

  1. Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) U01DK108328↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 4 shared papers, 1 shared grant, 2021–2026 · strength 1.38
  2. Eugene Jon Koay · 5 shared papers, 2022–2024 · strength 0.78
  3. Liang Li · 1 shared grant, 2026 · strength 0.77
  4. Ziding Feng · 1 shared grant, 2026 · strength 0.77
  5. Ying Yuan · 1 shared grant, 2026 · strength 0.77
  6. Subrata Sen · 5 shared papers, 2017–2026 · strength 0.75
  7. Ann McNeill Killary · 5 shared papers, 2017–2026 · strength 0.75
  8. Seetharaman Balasenthil · 4 shared papers, 2017–2026 · strength 0.63
  9. Randall E. Brand · 4 shared papers, 2017–2024 · strength 0.50
  10. Matthew H. G. Katz · 3 shared papers, 2022–2024 · strength 0.45
  11. Sudhir Srivastava · 3 shared papers, 2017–2026 · strength 0.45
  12. Lynette M. Smith · 2 shared papers, 2024–2026 · strength 0.39
  13. Ann L. Oberg · 2 shared papers, 2024–2026 · strength 0.39
  14. Michael Goggins · 2 shared papers, 2024–2026 · strength 0.39
  15. Brian Matthew Wolpin · 2 shared papers, 2024–2026 · strength 0.39
  16. Shounak Majumder · 2 shared papers, 2024–2026 · strength 0.39
  17. Kenneth Zaret · 2 shared papers, 2024–2026 · strength 0.39
  18. Albert C. Koong · 2 shared papers, 2024 · strength 0.31
  19. Jason A. Willis · 2 shared papers, 2024 · strength 0.31
  20. Grace L. Smith · 2 shared papers, 2024 · strength 0.31
  21. Cullen M. Taniguchi · 2 shared papers, 2024 · strength 0.31
  22. Ethan Bernard Ludmir · 2 shared papers, 2024 · strength 0.31
  23. Robert A. Wolff · 2 shared papers, 2022–2024 · strength 0.29
  24. Shubham Pant · 2 shared papers, 2022–2024 · strength 0.29
  25. Masataka Hayashi · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.